Data show that the cancer vaccine Cylembio plus Keytruda demonstrated clinical improvement in progression-free survival in ...

A nationwide survey of patients and caregivers has found educational and financial disparities in brain cancer care.

It is important to expand clinical trial access for patients with kidney cancer in order to ensure a representative study population.

The FDA has granted fast track designation to HLD-0915 for metastatic castration-resistant prostate cancer. The U.S. Food and ...

Intensive chemotherapy improved survival in patients with accelerated and blast phase myeloproliferative neoplasms, with ...

A diagnosis of breast cancer isn’t something most people would think of as a teacher, but sometimes important lessons come to ...

Cancer treatments can speed up aging in survivors, according to research, which can contribute to a person's risk for ...

Dr. Jim Omel, who was diagnosed with multiple myeloma in 1997, explained how the treatment landscape has changed over nearly ...

Dr. Jacob Sands explained that he believes patients should be having more personalized, nuanced conversations with their ...

Dr. Zev Wainberg of UCLA recently spoke with CURE about trial results concerning the cancer vaccine ELI-002 2P.

There are many reliable resources available to patients with kidney cancer, as well as their families and caregivers.

Living with stage 4 cancer taught me the power of community; connecting with others provides guidance, support, and hope in ...